[Study on the origin of H/RS cell and their biological behavior in Hodgkin lymphoma by using multiple mark techniques]

Zhonghua Xue Ye Xue Za Zhi. 2004 Oct;25(10):579-82.
[Article in Chinese]

Abstract

Objective: To investigate the apoptosis-related genes and protein expression patterns in relation to classical Hodgkin lymphomas (CHL) and the origin of H/RS cell.

Methods: Sixty-two cases of CHL were retrieved from Shanxi Tumor Hospital files. An ABC method was used to detect the expression of bcl-2, CD3, CD20, CD30, CD15 and CD10, a double immunohistochemical method to study the H/RS cells P53 expression, a double immunohistochemical ABC-DNA end labeling technique to detect the apoptosis, a double immunohistochemical ABC- in situ hybridization technique to detect the expression of kappa mRNA and lambda mRNA, and a multiple mark techniques to detect the distribution of background non-neoplastic T and B cells.

Result: Of 62 CHL, 14 (22.58%) were p53 positive and 35 (56.45%) bcl-2 positive. Apoptosis was found in the background non-neoplastic cells in all of the cases, but in H/RS cells in only 10 of 62 cases. There was a significant reverse correlation between bcl-2 expression and apoptosis in H/RS cells (P = 0.02). CD30 positive H/RS cells were observed in all cases, whereas CD15 positive in only 41 cases, and CD20 positive in 8 cases. None was positive for CD3, MPO, bcl-6, CD10, kappa RNA and lambda RNA in H/RS cells. The H/RS cells were surrounded by non-neoplastic T cells looked like a rosette and the outer periphery was B cells.

Conclusions: The H/RS cell of classical Hodgkin lymphoma has a great variety of B lineage markers. The characteristic distributions of T, B and H/RS cells may serve as a reference for the diagnosis. Multiple marker technique is able to highlight the critical cells, and facilitate the study of H/RS cells. Abnormal expression of P53 may not play a major role in CHL. Over expression of bcl-2 may be linked to blockage of apoptosis in CHL.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antigens, CD20 / genetics
  • Antigens, CD20 / metabolism
  • Apoptosis*
  • Biomarkers, Tumor / genetics
  • Biomarkers, Tumor / metabolism*
  • CD3 Complex / genetics
  • CD3 Complex / metabolism
  • Child
  • Child, Preschool
  • Hodgkin Disease / metabolism
  • Hodgkin Disease / pathology*
  • Humans
  • Immunohistochemistry
  • In Situ Hybridization
  • In Situ Nick-End Labeling
  • Ki-1 Antigen / genetics
  • Ki-1 Antigen / metabolism
  • Lewis X Antigen / genetics
  • Lewis X Antigen / metabolism
  • Middle Aged
  • Neprilysin / genetics
  • Neprilysin / metabolism
  • Proto-Oncogene Proteins c-bcl-2 / genetics
  • Proto-Oncogene Proteins c-bcl-2 / metabolism
  • Reed-Sternberg Cells / metabolism
  • Reed-Sternberg Cells / pathology*
  • Tumor Suppressor Protein p53 / genetics
  • Tumor Suppressor Protein p53 / metabolism
  • Young Adult

Substances

  • Antigens, CD20
  • Biomarkers, Tumor
  • CD3 Complex
  • Ki-1 Antigen
  • Lewis X Antigen
  • Proto-Oncogene Proteins c-bcl-2
  • Tumor Suppressor Protein p53
  • Neprilysin